Abstract:Induction chemotherapy or concurrent chemotherapy with radiotherapy can preserve laryngeal function without a detrimental effect on survival in patients with advanced laryngeal cancer. However, systemic chemotherapy with traditional injection often causes side effects. In this study, methoxy poly(ethylene glycol)-poly(lactide-co-glycolide) (MPEG-PLGA) nanoparticles (NPs) were developed as a carrier for paclitaxel, a potent cytotoxic agent. The NPs were prepared by an emulsification-solvent evaporation method with the particle size and zeta potential around 153.3 +/- 41.7 nm and -5.36 mV. Transmission electron microscopy showed that the NPs were homogeneous and spherical in shape. Differential scanning calorimetry and X-ray powder diffractometry did not detect any crystalline drug in the NP samples. High-performance liquid chromatography was used to measure the drug loading, encapsulation efficiency, and in-vitro drug release. The drug loading efficiency was (5.35 +/- 0.75)% and encapsulation efficiency was (75.56 +/- 2.61)%. In the in-vitro drug release study, paclitaxel was released from the NPs; in a slow but time-dependent manner. In-vitro cytotoxicity of the paclitaxel-loaded NPs was investigated by using human laryngeal cancer Hep-2 cells. The anticancer activity of paclitaxel-loaded NPs was comparable with the free paclitaxel. No significant cytotoxicity was observed in blank MPEG-PLGA Nips. Laser scanning confocal microscopy was used to observe the uptake of fluorescent coumarin-6-loaded NPs by Hep-2 cells. We conclude that the formulation of Nips inhibits Hep-2 cell growth to a similar extent as free paclitaxel injection. These results suggest that MPEG-PLGA NPs may have potential as an alternative delivery system for paclitaxel. Anti-Cancer Drugs 20:807-814 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Effects of Paclitaxel on the Proliferative Activity and Surface Ultrastructure of Daudi Cells in Vitro

The Inhibiting Effect of Combination of Allicin with Paclitaxel on Proliferation of Gastric Cancer Cells and Promotion of Apoptosis

Study on Taxol in Inhibiting Human Leukemia Cell Proliferation and Inducing Apoptosis

Inhibitory Effects of Paclitaxel on Human Embryonal Rhabdomyosarcoma Cell Line RD

Experimental studies on paclitaxel - induced apoptosis and growth inhibitory effects in Ewing sarcoma cell line of RD-ES in Vitro

Antiproliferative effects of paclitaxel (Taxol) on human renal clear cell carcinomas in vitro

Immunosuppressive Effect of Paclitaxel Liposome on B Lymphocytes

Effects of Taxol on Three Different Types of Lymphoma Cell Lines

Effect of Liposome Encapsulated Paelitaxel on Cervical Carcinoma Cells in Vitro

Sensitization of Decitabine Combined with Paclitaxel on Proliferation Inhibition and Apoptosis Induction of Paclitaxel-resistant MCF-7 Cells

Study On Inhibitory Effect Of Paclitaxel On Mek And Erk Protein Overexpression And Activation In Different Breast Cancer Cell Lines

In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.

Targeted Inhibition of Notch1 Gene Enhances the Killing Effects of Paclitaxel on Triple Negative Breast Cancer Cells.

Paclitaxel Liposome: Its in Vitro Killing Effect on Endometrial Carcinoma HEC-1A Cells

Selective Impairment of CD4 + CD25 + Foxp3 + Regulatory T Cells by Paclitaxel is Explained by Bcl-2/Bax Mediated Apoptosis

Immunomodulatory Effects of Docetaxel on Human Lymphocytes

Differential Impairment of Regulatory T Cells Rather Than Effector T Cells by Paclitaxel-Based Chemotherapy.

[Study of Sequence-Dependent in Vitro Effects of Zoledronic Acid and Paclitaxel Upon DU145 Prostate Cancer Cells].

Paclitaxel inhibits proliferation by negatively regulating Cdk1-cell cycle axis in rat airway smooth muscle cells

Study on Biological Characteristics and Mechanism of Paclitaxel Induced Drug Resistance in Endometrial Carcinoma Cells

Mechanisms of epidermal growth factor receptor in paclitaxel resistance of melanoma